TMS explained for St. Louis adults tired of another pill

Maybe you have tried two antidepressants, or three. One flattened you. One did nothing at all. You are not against treatment; you are tired of a daily pill and the wait to learn what it will cost you this time. If that is familiar, you belong to a large and mostly overlooked group.

When we commissioned a poll of 443 people from Missouri plus nine other states in the region, a clear majority said a depression treatment without drugs would matter to them, and very few knew that one is widely available. This explainer is for readers around St. Louis who want to understand that option, called TMS, in plain English.

What people told us

Our questionnaire asked respondents two things together: did TMS ring a bell, and would avoiding medication matter? Half of them, 51 percent, landed in one group: TMS was unfamiliar, but drug-free mattered. Another 13 percent were familiar with TMS and felt strongly about avoiding medication, 25 percent neither knew it nor much cared about avoiding drugs, and 12 percent recognized it but shrugged at the drug-free angle.

Combined, 64 percent of respondents value avoiding drugs, yet only 25 percent could explain TMS. These figures are final, and they measure awareness and preference, not how well TMS works.

TMS in plain terms

In transcranial magnetic stimulation, a coil resting on your head fires short magnetic bursts at an area of the brain that shapes mood. The field passes through the skull and induces small currents in the nerve cells below, with the aim of waking up areas that tend to run quiet in depression.

A few details surprise people:

• You stay awake. No anesthesia, no sedation. You sit in a chair.
• It clicks. The pulses make a tapping noise, and most clinics hand out earplugs.
• You can usually drive. Most patients head back to work or errands afterward.
• It differs from ECT. Shock therapy involves anesthesia and an intentional seizure, and TMS has neither.

Is it FDA-approved?

We hear this more than any other question, and the honest answer comes with a nuance. TMS devices hold FDA clearance to treat adults with major depression after antidepressants have not helped. Clearance is how many medical devices reach the market; it differs from drug approval, but it is a genuine review.

That nuance matters to many readers. Our survey found 59 percent of respondents saying the FDA's stamp would decide, or heavily sway, whether they tried something new, so if that is you, ask each clinic to name its device and the condition the FDA cleared it for.

What a course looks like

Plan on near-daily weekday sessions for several weeks, then a taper. Visits are fairly brief, apart from the first, when the clinician spends extra time mapping the target spot and dose. Some clinics now offer accelerated schedules; ask whether one would suit you.

Patients mostly mention a tender scalp and headaches, both of which tend to fade as sessions continue. Seizures are a rare but serious risk, so you will be screened for past seizures or metal implanted near the head. Fit is a judgment for a clinician familiar with your history.

The St. Louis logistics question

For many people here, the hard part is not the treatment but the calendar. When the visits come almost daily for weeks, the drive matters as much as the device.

Respondents grasped that. Choosing their top two factors in a provider, 43 percent of them named nearness to home, second only to insurance. In a metro stretching from St. Charles County to the Metro East, a clinic twenty minutes away and one an hour away are very different promises when you go most weekdays.

Before you start, think about:

• Whether a clinic near work beats one near home, since a session can often fit before or after a shift.
• Whether MetroLink or MetroBus reaches the clinic, if driving is hard or you have no car.
• Whether you would cross the river between Missouri and Illinois, since plan networks can change on the other side.

Paying for it

Coverage was the biggest concern respondents raised, with 85 percent listing insurance among their top two provider priorities. Many plans cover TMS for depression, usually after prior authorization and proof that antidepressants did not help enough.

If you carry MO HealthNet, Missouri's Medicaid program, or one of its managed care plans, call member services to confirm coverage of TMS for depression and the paperwork required. Commercial and Medicare members should ask the same, and then ask the clinic whether it will file the prior authorization. Many will.

How TMS differs from esketamine

Much of our survey dealt with ketamine and esketamine, so readers ask how TMS compares. Esketamine, sold as Spravato, is a medication: a nasal spray whose FDA approval covers treatment-resistant depression, used only while staff watch over you at a certified site. TMS uses no medication at all. People weigh both after standard antidepressants fall short, and neither suits everyone. Brain Recovery Centers explains the esketamine side in its guide to Spravato treatment.

Where to start

Start with your primary care doctor or current prescriber. Among our respondents, 56 percent would first bring a new depression treatment up with a primary doctor, and 74 percent said their own doctor's advice would be what moved them. You can simply ask: "Is TMS worth considering for me, and could you refer me?"

If suicidal thoughts come or you feel unsafe, skip the referral wait. Calling or texting 988 is free and confidential, and someone answers around the clock.

Methodology

Pollfish fielded this study on its consumer panel, and the final tally when fieldwork ended on June 23, 2026, was 443 completes. Everyone who took part was between 18 and 64, gave consent at the start, and resided somewhere in a ten-state Midwest footprint stretching from Ohio to Oklahoma. When a question allowed several answers, each figure is a share of all respondents. The numbers are final and validated. The publisher both commissioned the study and footed the bill.